321 - Oral Abstract Session
Reducing the Impact of Infections on Transplant Patients (Videos Available)

Monday July 02, 2018 | 09:45 to 11:15
Room: N-107/108
Track: Infectious Diseases


Camille Kotton, United States
A prospective multi-center observational trial to evaluate a CMV-specific ELIspot Assay in solid organ transplant (SOT) recipients: The PROTECT study (Video Available)

Prof. Bernhard Banas, Germany
Clinical validation of a novel ELISpot-based in vitro diagnostic assay to monitor CMV-specific cell-mediated immunity in kidney transplant recipients

Mr. Maciej Zieliński, Poland
Significance of cytomegalovirus specific T lymphocytes in kidney transplant recipients (Video Available)

Dr. Teresa Bellón, Spain
High frequencies of CMV-specific CD8 and CD4 T Cell cell subsets are needed pretransplant to protect from CMV replication in kidney transplant recipients treated with thymoglobulin (Video Available)

Dr. Eva M. Teegen, Germany
Treatment of HBV-recurrence after liver transplantation – 30 years of experience

Dr. Peter V ChinHong, United States
High incidence of anal human papillomavirus infection in HIV-infected solid organ transplant recipients (Video Available)

Dr. Dieter Hoyer, Germany
Risk factors for fungal infections after liver transplantation: A matched cohort analysis (Video Available)

Dr. Anwar Naqvi, Pakistan
INH prophylaxis in renal transplant recipients: A follow-up of 5 years

Dr. Nicole M. Theodoropoulos, United States
HIV, HBV, AND HCV Screening with NAT AND Serology in the OPO Setting (Video Available)

© 2022 TTS2018